In this section

Corrigendum to "In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2" [Lung Cancer 53 (3) (September 2006) 273-284].

Finan, K. M., Hodge, G., Reynolds, A. M., Hodge, S., Holmes, M. D., Baker, A. H. and Reynolds, P. N. (2016) Corrigendum to "In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2" [Lung Cancer 53 (3) (September 2006) 273-284]. Lung Cancer, 101, p. 149. (doi: 10.1016/j.lungcan.2016.06.002) (PMID:27312600)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Erratum)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Baker, Professor Andrew
Authors: Finan, K. M., Hodge, G., Reynolds, A. M., Hodge, S., Holmes, M. D., Baker, A. H., and Reynolds, P. N.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Lung Cancer
Publisher:Elsevier
ISSN:0169-5002
ISSN (Online):1872-8332
Published Online:13 June 2016

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details